4Schaumberg DA,Tomlinson A,Nichols JJ,et al. The internation- al workshop on meibomian gland dysfunction[J]. Invest Ophthal- mol Vis Sci,2011,52(4) : 1994-2046.
5Romero JM, Biser SA, Perry HD, et al. Conservative treatment of meibomian gland dysfunction [J ]. Eye Contact Lens, 2004,30: 14-19.
6Ozcura FS, Aydin MR, Helvaci. Ocular surface disease index for the diagnosis of dry eye syndrome[J]. Ocul Immunol In- flamm, 2007,15(5) :389-393.
7Souchier M, Joffre C, Gr6goire S, et al. Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment [J]. Br J Ophthalmol, 2008,92 : 819-822.
8Souchier M, Joffre C, Gr6goire S, et al. Changes in meibomianfatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment [Jl. Br J Ophthalmol, 2008,92: 819-822.
9Federici T,L The non-antibiotic properties of tetracyclines:clini- cal potential in ophthalmic disease [J]. Pharmacol Reseach, 2011,64 : 614-623.
10Maskin SL. Intraductal meibomian gland probing relieves symp- toms of obstructive meibomian gland dysfunction [J]. Cornea, 2010,29:1145-1152.
